Cargando…

Management of anemia in inflammatory bowel disease: a challenge in everyday clinical practice

Anemia is the most common extraintestinal manifestation and complication of inflammatory bowel disease (IBD). Its etiology is multifactorial and mostly is a combination of iron deficiency anemia (IDA) and chronic anemia (ACD). Because of its high incidence in patients with IBD and its influence on t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tulewicz-Marti, Edyta, Moniuszko, Andrzej, Rydzewska, Grażyna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2017
Materias:	Review Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771446/ https://www.ncbi.nlm.nih.gov/pubmed/29358991 http://dx.doi.org/10.5114/pg.2017.72096

Ejemplares similares

Management of anaemia in patients with inflammatory bowel disease – results of a questionnaire among Polish healthcare professionals
por: Tulewicz-Marti, Edyta M., et al.
Publicado: (2021)

Bone Metabolism Alteration in Patients with Inflammatory Bowel Disease
por: Tulewicz-Marti, Edyta Maria, et al.
Publicado: (2022)

Biomarkers in management of inflammatory bowel disease
por: Moniuszko, Andrzej, et al.
Publicado: (2013)

Awareness and Compliance with the Recommendations of Primary and Secondary Prevention of Cancer in Patients with Inflammatory Bowel Disease
por: Tulewicz-Marti, Edyta, et al.
Publicado: (2023)

Risk Factors for Osteoporosis among Patients with Inflammatory Bowel Disease—Do We Already Know Everything?
por: Lewandowski, Konrad, et al.
Publicado: (2023)

The effect of cyclic rifaximin therapy on symptoms of diverticular disease from the perspective of the gastroenterology outpatient clinic: a “real-life” study
por: Moniuszko, Andrzej, et al.
Publicado: (2017)

Effect of Intravenous Iron Administration on Bone Mineral and Iron Homeostasis in Patients with Inflammatory Bowel Disease—Results of a Prospective Single-Centre Study
por: Tulewicz-Marti, Edyta, et al.
Publicado: (2023)

Long-lasting dyspeptic symptoms – another consequence of the COVID-19 pandemic?
por: Nazarewska, Anna, et al.
Publicado: (2023)

The efficacy and safety of the biosimilar product (Inflectra(®)) compared to the reference drug (Remicade(®)) in rescue therapy in adult patients with ulcerative colitis
por: Kaniewska, Magdalena, et al.
Publicado: (2017)

Assessment of sexual dysfunction in patients with inflammatory bowel disease
por: Szydlarska, Dorota, et al.
Publicado: (2019)

Biosimilar infliximab versus originator in Crohn’s disease anti-TNF-α naïve and non-naïve patients
por: Kaniewska, Magdalena, et al.
Publicado: (2020)

New pharmaceuticals in inflammatory bowel disease
por: Łodyga, Michał, et al.
Publicado: (2015)

Biosimilar biological drugs in the treatment of inflammatory bowel diseases
por: Kaniewska, Magdalena, et al.
Publicado: (2019)

The position statement of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology regarding the management of patients with inflammatory bowel disease during the COVID-19 pandemic
por: Łodyga, Michał, et al.
Publicado: (2020)

Use of functional magnetic resonance imaging in patients with irritable bowel syndrome and functional dyspepsia
por: Skrobisz, Katarzyna, et al.
Publicado: (2019)

Management of iron deficiency anemia in inflammatory bowel disease – a practical approach
por: Stein, Jürgen, et al.
Publicado: (2013)

Demographic characteristics of children with early clinical manifestation of inflammatory bowel disease
por: Szymańska, Edyta, et al.
Publicado: (2015)

The introduction of the IBD Disk in Poland – a new tool for assessing disability in patients with inflammatory bowel disease
por: Eder, Piotr, et al.
Publicado: (2019)

Selected Aspects of Nutrition in the Prevention and Treatment of Inflammatory Bowel Disease
por: Panufnik, Paulina, et al.
Publicado: (2022)

Guidelines on the management of irritable bowel syndrome: In memory of Professor Witold Bartnik
por: Pietrzak, Anna, et al.
Publicado: (2018)

Successful treatment of an enterovesical fistula due to Crohn’s disease with stem cell transplantation: a case report
por: Moniuszko, Andrzej, et al.
Publicado: (2018)

Iron deficiency anaemia in patients with inflammatory bowel disease: National Consultant for Gastroenterology Working Group Recommendations
por: Kaniewska, Magdalena, et al.
Publicado: (2014)

The Use of Virtual Reality to Reduce Stress among Inflammatory Bowel Disease Patients Treated with Vedolizumab
por: Lewandowski, Konrad, et al.
Publicado: (2021)

Immature granulocytes predict severe acute pancreatitis independently of systemic inflammatory response syndrome
por: Lipiński, Michał, et al.
Publicado: (2017)

A Prospective Questionnaire-Based Study to Evaluate Factors Affecting the Decision to Receive COVID-19 Vaccination in 267 Patients with Inflammatory Bowel Disease in Poland
por: Łodyga, Michał, et al.
Publicado: (2022)

Imaging of Morphological Background in Selected Functional and Inflammatory Gastrointestinal Diseases in fMRI
por: Skrobisz, Katarzyna, et al.
Publicado: (2020)

The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome
por: Lewandowski, Konrad, et al.
Publicado: (2022)

Low-FODMAP Diet for the Management of Irritable Bowel Syndrome in Remission of IBD
por: Więcek, Martyna, et al.
Publicado: (2022)

The experience and awareness of laparoendoscopic procedures among Polish surgeons in everyday clinical practice
por: Mitura, Kryspin, et al.
Publicado: (2017)

Cardiorenal Syndrome: Challenges in Everyday Clinical Practice and Key Points towards a Better Management
por: Georgopoulou, Theodora, et al.
Publicado: (2023)

Position statement of the Polish Society of Gastroenterology and the National Gastroenterology Consultant on vaccination against COVID-19 among patients with inflammatory bowel diseases
por: Eder, Piotr, et al.
Publicado: (2021)

Sexual functions in individuals with inflammatory bowel diseases
por: Kotkowicz-Szczur, Marta, et al.
Publicado: (2023)

Biosimilar medicines – their use in the treatment of inflammatory bowel diseases. Position statement of the Working Group of the Polish National Consultant in Gastroenterology
por: Mularczyk, Aldona, et al.
Publicado: (2014)

Biological markers of disease activity in inflammatory bowel diseases
por: Szymanska, Edyta, et al.
Publicado: (2023)

The prevalence and clinical characteristics of anemia in Korean patients with inflammatory bowel disease
por: Lee, Dae Sung, et al.
Publicado: (2016)

Determination of antibodies in everyday rheumatological practice
por: Napiórkowska-Baran, Katarzyna, et al.
Publicado: (2019)

Management of Iron-Deficiency Anemia in Inflammatory Bowel Disease: A Systematic Review
por: Nielsen, Ole Haagen, et al.
Publicado: (2015)

Clostridium difficile infection in patients with inflammatory bowel disease
por: Czepiel, Jacek, et al.
Publicado: (2014)

Everyday life and Everyday Leisure
por: Veal, A.J
Publicado: (2023)

Relevance of Biotin Deficiency in Patients with Inflammatory Bowel Disease and Utility of Serum 3 Hydroxyisovaleryl Carnitine as a Practical Everyday Marker
por: Erbach, Johanna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hbmb7dgalv7nqqlhckkcn4a7i3